SSA
TDAC

Schonfeld Strategic Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
98,630
-51,371
-34% -$549K ﹤0.01% 1447
2026
Q1 		$1.59M Buy
150,001
+15,187
+11% +$160K 0.01% 913
2025
Q4 		$1.41M Hold
134,814
– – 0.01% 985
2025
Q3 		$1.4M Sell
134,814
-10,186
-7% -$105K 0.01% 1216
2025
Q2 		$1.49M Buy
145,000
+18,039
+14% +$183K 0.01% 1129
2025
Q1 		$1.28M Buy
+126,961
New +$1.28M 0.01% 1178

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.56% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

Schonfeld Strategic Advisors's TDAC Position: Q2 2026 in Review

Schonfeld Strategic Advisors reduced its Translational Development Acquisition Corp (TDAC) stake by 34% in Q2 2026, selling an estimated $549K and leaving 98,630 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Schonfeld Strategic Advisors first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.59M in Q1 2026. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Schonfeld Strategic Advisors held 98,630 shares of Translational Development Acquisition Corp worth $1.05M as of Q2 2026.
  • Schonfeld Strategic Advisors sold 51,371 Translational Development Acquisition Corp shares in Q2 2026, an estimated $549K.
  • Translational Development Acquisition Corp made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1447 holding.
  • Schonfeld Strategic Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Schonfeld Strategic Advisors's Translational Development Acquisition Corp position peaked at $1.59M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.